MRSA: Superbugs, A Super Business At Our Expense
African american doctor holding injection isolated on white background

MRSA: Superbugs, A Super Business At Our Expense

The CDC estimates 23,000 people a year in the U.S. die from antibiotic-resistant infections, like MRSA, and other nightmare superbugs. "Hospitals make three and a half times more money if they infect people. That’s why they don’t want to screen."

Continue Reading

The CBD Takeover: Big Pharma Makes Its Move with Epidiolex

Is the era of affordable, effective CBD oil coming to an end? Caught between CBD politics and Big Pharma's backing of the Federal Drug Administration, the industrial hemp industry, as well as thousands of chronic disease sufferers, fear the worst with the likely approval of GW Pharmaceutical's Epidiolex.

Continue Reading

End of content

No more pages to load

Close Menu
×

Cart